Substituted aminobenzimidazole pyrimidines as cyclin-dependent kinase inhibitors.

被引:0
|
作者
Verma, SK
Reddy, S
Nagarathnam, D
Shao, JX
Zhang, L
Zhao, J
Wang, YM
Li, T
Mull, E
Wang, CG
Zhu, QM
Altieri, M
Dang, TTA
Jordan, J
机构
[1] Bayer Pharmaceut, Dept Chem, West Haven, CT 06516 USA
[2] Bayer Pharmaceut, Dept Canc Res, West Haven, CT USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
232-MEDI
引用
收藏
页码:U949 / U949
页数:1
相关论文
共 50 条
  • [31] Advances in cyclin-dependent kinase inhibitors for the treatment of melanoma
    Julve, Maximilian
    Clark, James J.
    Lythgoe, Mark P.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (03) : 351 - 361
  • [32] Cyclin-Dependent Kinase Inhibitors and the Treatment of Gastrointestinal Cancers
    Mikhail, Sameh
    Albanese, Christopher
    Pishvaian, Michael J.
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2015, 185 (05): : 1185 - 1197
  • [33] Discovery and Development of Cyclin-Dependent Kinase 8 Inhibitors
    Lv, Xiao
    Tian, Yongbing
    Li, Shiyu
    Cheng, Kai
    Huang, Xufeng
    Kong, Haiyan
    Liao, Chenzhong
    Xie, Zhouling
    [J]. CURRENT MEDICINAL CHEMISTRY, 2020, 27 (32) : 5429 - 5443
  • [34] Cyclin-dependent kinase inhibitors and angiogenesis in sinonasal carcinomas
    Bottini, Consuelo
    Rossi, Valentina
    Valente, Guido
    Tessitore, Luciana
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [35] Novel potent pharmacological cyclin-dependent kinase inhibitors
    Wesierska-Gadek, Jozefa
    Chamrad, Ivo
    Krystof, Vladimir
    [J]. FUTURE MEDICINAL CHEMISTRY, 2009, 1 (09) : 1561 - 1581
  • [36] Expression of cyclin-dependent kinase inhibitors in vascular disease
    Tanner, FC
    Yang, ZY
    Duckers, E
    Gordon, D
    Nabel, GJ
    Nabel, EG
    [J]. CIRCULATION RESEARCH, 1998, 82 (03) : 396 - 403
  • [37] Role of Cyclin-Dependent Kinase Inhibitors in Endometrial Cancer
    Giannone, Gaia
    Tuninetti, Valentina
    Ghisoni, Eleonora
    Genta, Sofia
    Scotto, Giulia
    Mittica, Gloria
    Valabrega, Giorgio
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (09)
  • [38] Cyclin-dependent kinase inhibitors closer to market launch?
    Galons, Herve
    Oumata, Nassima
    Gloulou, Olfa
    Meijer, Laurent
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2013, 23 (08) : 945 - 963
  • [39] Cyclin-dependent kinase inhibitors move into Phase III
    Malini Guha
    [J]. Nature Reviews Drug Discovery, 2012, 11 : 892 - 894
  • [40] Functional analysis of cyclin-dependent kinase inhibitors of Arabidopsis
    De Veylder, L
    Beeckman, T
    Beemster, GTS
    Krols, L
    Terras, P
    Landrieu, I
    Van der Schueren, E
    Maes, S
    Naudts, M
    Inzé, D
    [J]. PLANT CELL, 2001, 13 (07): : 1653 - 1667